Alopecia Areata: Epidemiology Forecast to 2028

2019-07-31
Price :
Published : Jul-2019
No. of Pages : 31
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Alopecia Areata: Executive Summary
2.1 Related Reports
2.2 Upcoming Reports
3 Epidemiology
3.1 Disease Background
3.2 Risk Factors and Comorbidities
3.3 Global and Historical Trends
3.4 Forecast Methodology
3.4.1 Sources
3.4.2 Forecast Assumptions and Methods
3.4.3 Forecast Assumptions and Methods - Diagnosed Incident Cases of AA
3.4.4 Forecast Assumptions and Methods - Lifetime Diagnosed Prevalent Cases of AA
3.4.5 Forecast Assumptions and Methods - Diagnosed Incident Cases and Lifetime Diagnosed Prevalent Cases of AA by Severity
3.5 Epidemiological Forecast for AA (2018-2028)
3.5.1 Diagnosed Incident Cases of AA
3.5.2 Age-Specific Diagnosed Incident Cases of AA
3.5.3 Sex-Specific Diagnosed Incident Cases of AA
3.5.4 Diagnosed Incident Cases of AA by Severity
3.5.5 Lifetime Diagnosed Prevalent Cases of AA
3.5.6 Age-Specific Lifetime Diagnosed Prevalent Cases of AA
3.5.7 Sex-Specific Lifetime Diagnosed Prevalent Cases of AA
3.5.8 Lifetime Diagnosed Prevalent Cases of AA by Severity
3.6 Discussion
3.6.1 Epidemiological Forecast Insight
3.6.2 Limitations of Analysis
3.6.3 Strengths of Analysis
4 Appendix
4.1 Bibliography
4.2 About the Authors
4.2.1 Epidemiologists
4.2.2 Reviewers
4.2.3 Global Director of Therapy Analysis and Epidemiology
4.2.4 Global Head and EVP of Healthcare Operations and Strategy
4.3 About GlobalData
4.4 Contact Us
4.5 Disclaimer

List of Tables
Table 1: Risk Factors and Comorbidities for AA

List of Figures
Figure 1: 7MM, Diagnosed Incident Cases of AA, Both Sexes, All Ages , 2018 and 2028
Figure 2: 7MM, Lifetime Diagnosed Prevalent Cases of AA, Both Sexes, All Ages , 2018 and 2028
Figure 3: 7MM, Diagnosed Incidence of Alopecia Areata, Both Sexes, All Ages, 2018
Figure 4: 7MM, Lifetime Diagnosed Prevalence of Alopecia Areata, Both Sexes, All Ages, 2018
Figure 5: 7MM, Sources Used to Forecast the Diagnosed Incident Cases of Alopecia Areata
Figure 6: 7MM, Sources Used to Forecast the Lifetime Diagnosed Prevalent Cases of Alopecia Areata
Figure 7: 7MM, Sources Used to Forecast the Diagnosed Incident Cases and Lifetime Diagnosed Prevalent Cases by Severity of AA
Figure 8: 7MM, Diagnosed Incident Cases of AA, Both Sexes, All Ages, 2018
Figure 9: 7MM, Age-Specific Diagnosed Incident Cases of AA, Both Sexes, All Ages, 2018
Figure 10: 7MM, Sex-Specific Diagnosed Incident Cases of AA, All Ages, 2018
Figure 11: 7MM, Diagnosed Incident Cases of AA by Severity, Both Sexes, All Ages, 2018
Figure 12: 7MM, Lifetime Diagnosed Prevalent Cases of AA, Both Sexes, All Ages, 2018
Figure 13: 7MM, Age-Specific Lifetime Diagnosed Prevalent Cases of AA, Both Sexes, All Ages, 2018
Figure 14: 7MM, Sex-Specific Lifetime Diagnosed Prevalent Cases of AA, All Ages, 2018
Figure 15: 7MM, Lifetime Diagnosed Prevalent Cases of AA by Severity, Both Sexes, All Ages, 2018
Filed in: Pharmaceutical, Therapeutics
Publisher : GlobalData